Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain ...

Completion of the first implantation procedure marks the start of Abbott’s pivotal deep brain stimulation trial in ...

A team of experts from the Icahn School of Medicine at Mount Sinai has become the first in the United States to perform a ...

The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

On Feb 24, the FDA approved Medtronic’s BrainSense Adaptive deep brain stimulation, a device that surgeons implant in patients’ chests with electrodes connecting to the brain. The system is ...

PITTSBURGH--(BUSINESS WIRE)--Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “DeepFocus ...

Bhubaneswar: In a groundbreaking achievement, the Institute of Medical Sciences and SUM Hospital has succesfully conducted ...

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “DeepFocus,” uses transnasal electrical ...

Side effects of deep brain stimulation in people to treat Parkinson's may include impulsivity and depression. Biomedical ...